Publications Directory

Welcome to our Publications Directory. As Australia's peak allergy research body, here you will find the latest evidence out of the drug, food, insect and respiratory allergy studies involving our leading experts and scholars.

  • For advice on how to acknowledge your NACE affiliation if you are involved in research supported, conducted and/or funded by the NACE, see our Publications Guidelines
  • For more information about studies currently recruiting and underway across Australia, visit the NACE Allergy Studies Directory.
Filter by type:
  • Drug Allergy
    Drug allergy Aug 2024

    Comparing skin and serum testing to direct challenge outcomes in children with beta-lactam allergies.

    The Journal of Allergy and Clinical Immunology: In Practice.

    Read more

  • Drug Allergy
    Drug allergy Aug 2024

    The Australasian Registry for Severe Cutaneous Adverse Reactions (AUS-SCAR) - Providing a roadmap for closing the diagnostic, patient, and healthcare gaps for a group of rare drug eruptions

    World Allergy Organization Journal. 

    Read more

  • Drug Allergy
    Drug allergy Aug 2024

    Validation of a digital self-assessment to identify low-risk penicillin and sulfa antibiotic allergies in adults (SELF-FAST)

    The Journal of Allergy and Clinical Immunology: In Practice.

    Read more

  • Drug Allergy
    Drug allergy Jul 2024

    Effectiveness of direct delabelling of allergy labels in type A adverse drug reactions to penicillin: a multicentre hospitalwide prospective cohort study

    Journal of Antimicrobial Chemotherapy

    Read more

  • Drug Allergy
    Drug allergy Jul 2024

    Durability of penicillin allergy delabeling and post-testing penicillin utilization in adults with immune compromise

    The Journal of Allergy and Clinical Immunology: In Practice. 

    Read more

  • Drug Allergy
    Drug allergy May 2024

    Oral challenge vs routine care to assess low-risk penicillin allergy in critically ill hospital patients (ORACLE): a pilot safety and feasibility randomised controlled trial

    Intensive Care Medicine. 

    Read more

  • Drug Allergy
    Drug allergy Feb 2024

    Low-risk penicillin allergy delabeling: a scoping review of direct oral challenge practice, implementation, and multi-disciplinary approaches

    Taylor & Francis Online. 

    Read more

  • Drug Allergy
    Drug allergy Dec 2023

    Low-risk penicillin allergy delabeling: a scoping review of direct oral challenge practice, implementation, and multi-disciplinary approaches

    Expert Review of Anti-infective Therapy

    Read more

  • Drug Allergy
    Drug allergy Jul 2023

    Efficacy of a Clinical Decision Rule to Enable Direct Oral Challenge in Patients With Low-Risk Penicillin Allergy The PALACE Randomized Clinical Trial

    JAMA Internal Medicine.

    Read more

  • Drug Allergy
    Drug allergy Jul 2023

    The Who, What, When, and Where of Inpatient Direct Oral Penicillin Challenge-Implications for Health Services Implementation

    Clinical Infectious Diseases. 

    Read more

If you would like to request a PDF version of a full article, please email [email protected]

Stay informed 

Sign up for NACE news and allergy study updates

Subscribe

Become a member 

Are you part of the Australian and New Zealand allergy research community?

Join us

In proud partnership with